ABSTRACT
OBJECTIVE The density of pathological positive cells was calculated by flow cytometry, and the target cells were isolated and extracted to improve the detection rate.
DESIGN a case-control study.
SETTING Hematology Department of Hospital
PARTICIPANTS Selected from MDS 33 cases, 17 cases of malignant tumors, 29 cases of lupus erythematosus, 4 cases of plasmodium falciparum disease, a total of 76 cases as positive blood specimens.
MAIN OUTCOME MEASURES Design Research group (group I) : Flow cytometry was used to analyze and calculate the density of various cell types, and then cell separation solution was used to accurately separate and extract target cells of the same density by adjusting the gradient of two different densities, that is, to collect pathologically positive blood cells of the same density. A control group (group II) was established: the whole blood samples of the same patient were compared and analyzed by direct push-film observation.
RESULTS As shown in Figure 2AB-3AB-4AB-5AB, A large number of positive abnormal cells were extracted from group I, which improved the accuracy and specificity of diagnosis. In the control group (group II), only a few positive abnormal cells were found, which was very easy to misdiagnose and miss diagnosis. Data are analyzed from Table 3. According to the statistical results of group I, the positive detection rates were MDS=76%, malignant tumor cells =53%, lupus erythematosus cells =62%, Plasmodium falciparum =75%. In the control group (group II), the positive detection rate was MDS=27%, malignant tumor cells =11%, lupus erythematosus cells =33%, Plasmodium falciparum =25%. Chi-square test was used to compare the mean value of independent samples between groups, and the difference was statistically significant (P<0.05).
CONCLUSIONS The density of pathologically positive blood cells can be measured by flow cytometry according to the specimens that need to be reviewed by microscopy as indicated by blood routine, and the target cells extracted can be accurately separated, that is, the same density of pathologically positive blood cells can be collected. Combined with the gold standard method of artificial microscopy, the detection rate was significantly improved, and the occurrence of misdiagnosis and missed diagnosis was reduced. For the difference in cell density of various forms in different types of specimens, it only needs to be distinguished from normal cell density, and abnormal pathological positive cells can be accurately extracted, which can help diagnose the positive detection rate of diseases, which is of great significance and value
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Sihui People's Hospital, Level 3A Hospital's Medical central laboratory (GuangDong province,CHINA 526200) Medical Ethics Expert Committee of Sihui City Health Management Department Approval Number (ID Number): (Medical Review 2023 No. 61) 2023-061
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
